| |
| |
|
| Insider
Information: |
Ramsay David A |
| Relationship: |
Director |
| City: |
San Diego, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,587,962 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$26,197,643 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,587,962 |
|
|
| Total
Value |
$26,197,643 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
0
|
|
Stock
price went up :
|
46
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
5.8
|
0.0
|
| Percentage
Gain/Loss : |
 71.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
VP and Chief Financial... |
2015-02-06 |
364,320 |
|
0 |
Premium* |
|
|
Savara Inc |
SVRA |
Director |
2023-12-14 |
2,223,642 |
2012-05-09 |
0 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Director |
2022-08-22 |
0 |
2020-08-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-12-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,625 |
361,175 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Director |
– • – |
2021-05-24 |
4 |
B |
$3.44 |
$69,838 |
D/D |
20,000 |
68,000 |
2.39 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-12-01 |
4 |
OE |
$2.02 |
$40,517 |
D/D |
20,058 |
343,550 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-08-30 |
4 |
B |
$1.41 |
$29,261 |
D/D |
20,738 |
1,621,880 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2017-06-07 |
4 |
B |
$4.75 |
$99,750 |
D/D |
21,000 |
22,428 |
2.39 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-06-21 |
4 |
B |
$1.38 |
$29,110 |
D/D |
21,094 |
1,562,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2019-06-27 |
4 |
B |
$2.38 |
$53,774 |
D/D |
22,300 |
86,985 |
2.39 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
2,223,642 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-09-16 |
4 |
B |
$8.90 |
$222,500 |
D/D |
25,000 |
323,492 |
2.74 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2019-06-17 |
4 |
B |
$2.37 |
$59,550 |
D/D |
25,000 |
48,570 |
2.39 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-12-17 |
4 |
B |
$1.13 |
$28,225 |
D/D |
25,000 |
1,451,142 |
2.39 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-11-21 |
4 |
B |
$1.42 |
$35,532 |
D/D |
25,005 |
1,926,147 |
2.39 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Director |
– • – |
2020-08-21 |
4 |
B |
$3.84 |
$111,108 |
D/D |
28,000 |
40,000 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-08 |
4 |
B |
$1.40 |
$40,571 |
D/D |
29,000 |
1,733,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-30 |
4 |
B |
$1.55 |
$44,834 |
D/D |
29,000 |
2,101,142 |
2.39 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2007-07-26 |
4 |
OE |
$0.39 |
$11,700 |
D/D |
30,000 |
401,410 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-23 |
4 |
B |
$1.42 |
$42,660 |
D/D |
30,000 |
1,771,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-08-18 |
4 |
B |
$1.18 |
$36,980 |
D/D |
30,736 |
964,090 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-26 |
4 |
B |
$1.38 |
$43,052 |
D/D |
31,107 |
1,802,249 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-12-10 |
4 |
B |
$1.04 |
$36,365 |
D/D |
35,000 |
1,411,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-12-30 |
4 |
B |
$1.30 |
$45,360 |
D/D |
35,000 |
1,501,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2019-06-28 |
4 |
B |
$2.33 |
$82,309 |
D/D |
35,157 |
122,142 |
2.39 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-05-26 |
4 |
B |
$2.63 |
$97,599 |
D/D |
37,124 |
2,201,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-06-22 |
4 |
B |
$1.45 |
$56,355 |
D/D |
39,000 |
1,601,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-08-31 |
4 |
B |
$1.42 |
$56,200 |
D/D |
39,494 |
1,661,374 |
2.39 |
% |
|
93 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
